<div>
  <ul>
    <li>
      <p>
        Chronic management care company Vivante Health has raised USD 31 million in a Series B funding round led by Mercato Partners with participation from investors such as Health Catalyst Capital, 7wireVentures, and Intermountain Ventures. This brings the total funds raised by the company to USD 47 million.
      </p>
    </li>
    <li>
      <p>
        The funds will support Vivante&rsquo;s technology upgrades to predict and manage gastrointestinal (GI) conditions as well as the expansion of commercial and client support teams.
      </p>
    </li>
  </ul>
  <p>
  </p>
</div>


<div>
  <p>
    <a href="https://vivantehealth.com/blog/press-releases/vivante-health-closes-31million-series-b-round-to-advance-digital-health-platform/">
      Company Press Release
    </a>
  </p>
</div>


Preventive Healthcare

DISRUPTOR_PRESENT

Chronic management care company, Vivante Health, has secured $31 million in a Series B funding round, bringing the total funds raised by the company to $47 million. Led by Mercato Partners, the funding round also saw participation from investors including Health Catalyst Capital, 7wireVentures, and Intermountain Ventures. The funds will be used to enhance Vivante's technology in predicting and managing gastrointestinal (GI) conditions, as well as expanding its commercial and client support teams.

Vivante Health raises USD 31 million in Series B funding

PROMINENT_CATEGORY

Privia Health has partnered with Navina to improve workflows and support value-based care. Through the collaboration, Privia Health's network will have access to Navina's AI technology, which can read and interpret patient data to generate clinical summaries and evidence-based recommendations. This collaboration aims to improve patient care and reduce administrative burden for physicians and providers.

Privia Health and Navina partners to enhance provider workflow

Virtual heart health clinic, Miga, has joined forces with self-funded health insurance provider, Sana, to offer Miga's heart health program to over 25,000 Sana Benefits members. The program aims to prevent heart attacks and strokes through a focus on improving risk factors such as obesity, hypertension, diabetes, and hyperlipidemia. Miga's program includes personalized plans, data monitoring, lifestyle interventions, and clinical services provided by a multidisciplinary care team. This partnership will allow Sana members across 10 states to access Miga's heart health program, enhancing their overall health and well-being.

Miga partners with Sana Benefits to expand access to cardiovascular care

INCUMBENTS_PRESENT

Abbott, a healthcare company, has agreed to acquire chronic care management company Bigfoot Biomedical, with the deal expected to be completed in Q3 2023. This acquisition follows a partnership between the two companies in 2017 and subsequent investments by Abbott in Bigfoot. Bigfoot developed the Bigfoot Unity system, a smart insulin system that uses connected insulin pen caps and continuous glucose monitoring data to provide insulin dosing recommendations. The system was initially designed to work with Abbott's FreeStyle Libre technology and includes a mobile app for users and a cloud-based portal for healthcare providers. The companies aim to advance tech-driven solutions for personalized diabetes management.

Abbott plans Bigfoot Biomedical acquisition to advance connected diabetes solutions

Idoven, an AI-powered cardiology platform based in Spain, has secured funding in a round led by Northzone and Insight Partners. The amount of funding raised has not been disclosed. NBA champion Pau Gasol, Hambro Perks, Adam Chekroud, and Luis Sanz also participated in the round. The funds will be utilized to speed up the release of new solutions based on the company's core technology, aid healthcare professionals in diagnosing cardiovascular diseases, and expand the company's presence in other regions.

Idoven raises undisclosed amount in new funding

Amir Dan Rubin, CEO of One Medical, will be leaving his role after over six years with the company. He has been at the helm since 2017 and will step down at the end of his term. Trent Green, the current COO of One Medical, will take over as CEO later this year.

One Medical CEO steps down one year after Amazon acquisition

Massachusetts-based company Beta Bionics has raised $100 million in Series D funding to expand access to its iLet Bionic Pancreas across the US and further develop and test the bi-hormonal bionic pancreas. The funding was co-led by Sands Capital and Omega Funds, with participation from Marshall Wace and existing investors including Soleus Capital and Farallon Capital. Beta Bionics has developed the iLet Bionic Pancreas, an automated insulin delivery system that eliminates the need for traditional setup, carb counting, corrections, and calculating boluses. The iLet Bionic Pancreas uses adaptive, self-learning control algorithms with continuous glucose monitoring and pump technology.

Beta Bionics raises USD 100 million in Series D funding

Israel-based FemTech company Nevia Bio has secured $3.1 million in seed funding, led by MindUP Digital Health Incubator. The investment will be used to progress clinical trials for its ovarian cancer program, which utilizes biomarker data from vaginal secretions for early detection. In addition to this, the funding will be used to expand the company's range of solutions in women's health and enhance its data science capabilities. Nevia Bio has developed a platform that leverages machine learning and data science techniques to identify unique biomarkers, facilitating early disease detection in women.

Nevia Bio raises USD 3.1 million in seed funding

Oak Street Health has partnered with Strive Health to offer treatment to patients with severe chronic kidney disease (CKD). The collaboration combines Strive's expertise in value-based kidney care with Oak Street Health's clinical care model for older adults on Medicare. The goal is to provide specialized population health capabilities and resources to help individuals with CKD delay disease progression and improve their quality of life. Strive Health's CareMultiplier technology will be utilized to collect data, assess disease progression, and make predictions about a patient's condition.

All Updates